Brief: Initiator Pharma Resolves On Rights Issue Of SEK 56 Mln
May 19 (Reuters) - Initiator Pharma A/S INIT.ST: THE BOARD OF DIRECTORS OF INITIATOR PHARMA A/S RESOLVES ON A RIGHTS ISSUE AMOUNTING TO SEK 56M SUBSCRIPTION RIGHTS ALLOCATED, PRICE SET AT 4.0 SEK PER SHARE NET PROCEEDS FROM RIGHTS ISSUE ARE EXPECTED TO FINANCE INITIATOR WELL INTO 2027 GUARANTEE UNDERTAKINGS TOTAL SEK 33 MILLION, 59% OF RIGHTS ISSUE Source text: ID:nMFNlnYfF Further company coverage: INIT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD